Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 617323
                    [Title] => Pascual Lab eyes major share in local ED drug mart
                    [Summary] => 
Pascual Laboratories, Inc. (PLI) expects to grab a substantial share of the P200-million sildenafil market on its maiden year.
                    [DatePublished] => 2010-10-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

ZILDEN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 617323
                    [Title] => Pascual Lab eyes major share in local ED drug mart
                    [Summary] => 
Pascual Laboratories, Inc. (PLI) expects to grab a substantial share of the P200-million sildenafil market on its maiden year.
                    [DatePublished] => 2010-10-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Pascual Lab eyes major share in local ED drug mart

October 4, 2010 - 12:00am

Pascual Laboratories, Inc. (PLI) expects to grab a substantial share of the P200-million sildenafil market on its maiden year.

Business